These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 38807338)
1. Safety and Effectiveness of Passeo-18 Lux Drug-Coated Balloon Catheter in Infrainguinal Endovascular Revascularization in the Korean Population: A Multicenter Post-Market Surveillance Study. Choi TW; Won JH; Jae HJ; Jeon YS; Park SW; Ko GY; Yim NY; Won JY; Kim CW; Kim J Korean J Radiol; 2024 Jun; 25(6):565-574. PubMed ID: 38807338 [TBL] [Abstract][Full Text] [Related]
2. Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry. Tepe G; Zeller T; Moscovic M; Corpataux JM; Christensen JK; Keirse K; Nano G; Schroeder H; Binkert CA; Brodmann M Cardiovasc Intervent Radiol; 2021 Feb; 44(2):207-217. PubMed ID: 33083853 [TBL] [Abstract][Full Text] [Related]
3. BIOLUX P-III Passeo-18 Lux All-Comers Registry: 24-Month Results in Below-the-Knee Arteries. Tepe G; Wang J; Corpataux JM; Pua U; Binkert CA; Moscovic M; Ghotbi R; Keirse K; Robertson D; Brodmann M Cardiovasc Intervent Radiol; 2021 Jan; 44(1):10-18. PubMed ID: 32964317 [TBL] [Abstract][Full Text] [Related]
4. Paclitaxel-Coated Balloon for the Treatment of Infrainguinal Disease: 12-Month Outcomes in the All-Comers Cohort of BIOLUX P-III Global Registry. Tepe G; Zeller T; Moscovic M; Corpataux JM; Christensen JK; Keirse K; Nano G; Schroeder H; Binkert CA; Brodmann M J Endovasc Ther; 2020 Apr; 27(2):304-315. PubMed ID: 31989855 [No Abstract] [Full Text] [Related]
5. Twenty-Four-Month Outcomes of Drug-Coated Balloon in Diabetic Patients in the BIOLUX P-III Registry: A Subgroup Analysis. Mwipatayi BP; Barry IP; Brodmann M; Zeller T; Varcoe RL; Moscovic M; Chian JWC; Christensen JK; Yahaya SA; Oshin OA; Tepe G; Ann Vasc Surg; 2021 Aug; 75():237-252. PubMed ID: 33831519 [TBL] [Abstract][Full Text] [Related]
6. Real-World Experience With a Paclitaxel-Coated Balloon in Critical Limb Ischemia: 24-Month Subgroup Outcomes of BIOLUX P-III. Brodmann M; Moscovic M; Wang JCC; Nano G; Dahm J; Zeller T; Christensen JK; Keirse K; Ghotbi R; Corpataux JM; Tepe G JACC Cardiovasc Interv; 2020 Oct; 13(19):2289-2299. PubMed ID: 32950415 [TBL] [Abstract][Full Text] [Related]
8. Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries). Zeller T; Beschorner U; Pilger E; Bosiers M; Deloose K; Peeters P; Scheinert D; Schulte KL; Rastan A; Brodmann M JACC Cardiovasc Interv; 2015 Oct; 8(12):1614-22. PubMed ID: 26493253 [TBL] [Abstract][Full Text] [Related]
9. Drug-Coated Balloon Angioplasty Compared With Uncoated Balloons in the Treatment of Infrapopliteal Artery Lesions (AcoArt II-BTK). Jia X; Zhuang B; Wang F; Gu Y; Zhang J; Lu X; Dai X; Liu Z; Bi W; Liu C; Wang S; Liistro F; Guo W J Endovasc Ther; 2021 Apr; 28(2):215-221. PubMed ID: 33118432 [TBL] [Abstract][Full Text] [Related]
10. Combining the Passeo-18 Lux Drug-Coated Balloon and the Pulsar-18 Bare Metal Stent: 12- and 24-Month Outcomes of the BIOLUX 4EVER Investigator-Initiated Trial. Deloose K; Bosiers M; Peeters P; Verbist J; Maene L; Beelen R; Keirse K; Hendriks J; Lauwers P; Wauters J; Verschueren M J Endovasc Ther; 2020 Dec; 27(6):936-945. PubMed ID: 32873131 [TBL] [Abstract][Full Text] [Related]
12. IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population. Chen Z; Guo W; Jiang W; Wang F; Fu W; Zou Y; Deckers S; Li P; Popma JJ; Jaff MR J Endovasc Ther; 2019 Aug; 26(4):471-478. PubMed ID: 31204595 [No Abstract] [Full Text] [Related]
13. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease. Imran HM; Hyder ON; Soukas PA Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328 [TBL] [Abstract][Full Text] [Related]
14. Methodology of the BIOPACT RCT, a Multi-center, Randomized, Non-inferiority Trial Evaluating Safety and Efficacy of Passeo-18 Lux Drug-Coated Balloon (DCB) of Biotronik Compared to the Medtronic IN.PACT Admiral DCB in the Treatment of Subjects with Lesions of the Femoropopliteal Artery. Deloose K; Lansink W; Brodmann M; Werner M; Keirse K; Gouëffic Y; Verbist J; Maene L; Hendriks J; Brunet J; Ducasse E; Levent K; Sauguet A; Déglise S; Vandael F Cardiovasc Intervent Radiol; 2022 Dec; 45(12):1855-1859. PubMed ID: 36058996 [TBL] [Abstract][Full Text] [Related]
15. Twenty-Four-Month Safety and Effectiveness of TCD-17187 Drug-Coated Balloon for Treatment of Atherosclerotic Lesions in Superficial Femoral and Proximal Popliteal Artery. Soga Y; Iida O; Seki SI; Kawasaki D; Anzai H; Ando H; Nakama T; Shinozaki N; Kozuki A; Ishihara M; Urasawa K; Toi S; Tsujita H; Tobita K; Ogata K; Horie K; Hayakawa N; Mori S; Fujihara M; Ohki T; Yuba K; Mano T; Ando K; Nakamura M; Cardiovasc Intervent Radiol; 2024 Jun; 47(6):730-740. PubMed ID: 38816504 [TBL] [Abstract][Full Text] [Related]
16. Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon). Schroeder H; Werner M; Meyer DR; Reimer P; Krüger K; Jaff MR; Brodmann M; Circulation; 2017 Jun; 135(23):2227-2236. PubMed ID: 28424223 [TBL] [Abstract][Full Text] [Related]
17. Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort. Brodmann M; Keirse K; Scheinert D; Spak L; Jaff MR; Schmahl R; Li P; Zeller T; JACC Cardiovasc Interv; 2017 Oct; 10(20):2113-2123. PubMed ID: 29050631 [TBL] [Abstract][Full Text] [Related]
18. MagicTouch PTA Sirolimus Coated Balloon for Femoropopliteal and Below the Knee Disease: Results From XTOSI Pilot Study Up To 12 Months. Choke E; Tang TY; Peh E; Damodharan K; Cheng SC; Tay JS; Finn AV J Endovasc Ther; 2022 Oct; 29(5):780-789. PubMed ID: 34911383 [TBL] [Abstract][Full Text] [Related]
19. The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes. Zeller T; Micari A; Scheinert D; Baumgartner I; Bosiers M; Vermassen FEG; Banyai M; Shishehbor MH; Wang H; Brodmann M; JACC Cardiovasc Interv; 2020 Feb; 13(4):431-443. PubMed ID: 32081236 [TBL] [Abstract][Full Text] [Related]
20. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study. Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]